UBS7 个月
GLP-1: A medication worth $126 billion in sales by 2029?
The uptake of GLP-1 has surged since 2022, mainly in US. Read our takeaways from the UBS Evidence Lab survey on key trends in GLP-1 consumer behaviour GLP-1s, also known as glucagon-like peptide 1, ...
The Economist22 天
GLP-1s like Ozempic are among the most important drug breakthroughs ever
A new class of drugs is set to join their ranks and has the potential to eclipse them all—GLP-1 receptor agonists. These drugs mimic the action of a naturally occurring hormone, glucagon-like ...
Ars Technica16 天
Ars Live: What else can GLP-1 drugs do? Join us today for a discussion.
News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to their astronomical pricing, drug shortages, compounding disputes ...
UPI20 天
Weight-loss surgeries decline 25% as GLP-1 drugs grow in popularity
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds. Prescriptions of this GLP-1 class ...